| 9.3°C Belfast

£294m deal for fat-busting firm

Drugs firm AstraZeneca has announced a $443m (£294m) deal to buy an American company developing a fat-busting treatment to combat a condition linked to heart attacks.

The British pharmaceuticals giant has acquired Omthera as the group prepares to file an application for approval in the US for Epanova.

Belfast Telegraph